AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

11,104.00p
   
  • Change Today:
    -220.00p
  • 52 Week High: 13,276.00p
  • 52 Week Low: 9,667.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.68m
  • Volume: 2,174,580
  • Market Cap: £172,188m
  • RiskGrade: 123
  • Beta: 0.01

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
34.79% above the market average34.79% above the market average34.79% above the market average34.79% above the market average34.79% above the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
1yr Revenue Growth
54.32% above the market average54.32% above the market average54.32% above the market average54.32% above the market average54.32% above the market average
10.34% above the sector average10.34% above the sector average10.34% above the sector average10.34% above the sector average10.34% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
47.75% below the market average47.75% below the market average47.75% below the market average47.75% below the market average47.75% below the market average
Sector averageSector averageSector averageSector averageSector average
1yr DPS Growth
21.68% above the market average21.68% above the market average21.68% above the market average21.68% above the market average21.68% above the market average
Sector averageSector averageSector averageSector averageSector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
82.34% below the market average82.34% below the market average82.34% below the market average82.34% below the market average82.34% below the market average
29.73% below the sector average29.73% below the sector average29.73% below the sector average29.73% below the sector average29.73% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
65.17% above the market average65.17% above the market average65.17% above the market average65.17% above the market average65.17% above the market average
37.78% above the sector average37.78% above the sector average37.78% above the sector average37.78% above the sector average37.78% above the sector average
Price Chg 3m
2.25% above the market average2.25% above the market average2.25% above the market average2.25% above the market average2.25% above the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
63.22% above the market average63.22% above the market average63.22% above the market average63.22% above the market average63.22% above the market average
46.34% above the sector average46.34% above the sector average46.34% above the sector average46.34% above the sector average46.34% above the sector average
Momentum 20
99.70% above the market average99.70% above the market average99.70% above the market average99.70% above the market average99.70% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
29.99% above the market average29.99% above the market average29.99% above the market average29.99% above the market average29.99% above the market average
73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average
ROCE
74.47% above the market average74.47% above the market average74.47% above the market average74.47% above the market average74.47% above the market average
7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
99.40% above the market average99.40% above the market average99.40% above the market average99.40% above the market average99.40% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Forecast EPS
96.57% above the market average96.57% above the market average96.57% above the market average96.57% above the market average96.57% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
98.81% above the market average98.81% above the market average98.81% above the market average98.81% above the market average98.81% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Operating Profit Loss
98.96% above the market average98.96% above the market average98.96% above the market average98.96% above the market average98.96% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
97.49% above the market average97.49% above the market average97.49% above the market average97.49% above the market average97.49% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Cash
96.80% above the market average96.80% above the market average96.80% above the market average96.80% above the market average96.80% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
90.23% above the market average90.23% above the market average90.23% above the market average90.23% above the market average90.23% above the market average
87.10% above the sector average87.10% above the sector average87.10% above the sector average87.10% above the sector average87.10% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
6.13% above the market average6.13% above the market average6.13% above the market average6.13% above the market average6.13% above the market average
Sector averageSector averageSector averageSector averageSector average
Brokers Percent Neutral
62.35% below the market average62.35% below the market average62.35% below the market average62.35% below the market average62.35% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 11,104.00p
Change Today -220.00p
% Change -1.94 %
52 Week High 13,276.00p
52 Week Low 9,667.00p
Volume 2,174,580
Shares Issued 1,550.68m
Market Cap £172,188m
Beta 0.01
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.11% below the market average94.11% below the market average94.11% below the market average94.11% below the market average94.11% below the market average
86.05% below the sector average86.05% below the sector average86.05% below the sector average86.05% below the sector average86.05% below the sector average
Price Trend
45.18% below the market average45.18% below the market average45.18% below the market average45.18% below the market average45.18% below the market average
91.11% above the sector average91.11% above the sector average91.11% above the sector average91.11% above the sector average91.11% above the sector average
Income
64.72% below the market average64.72% below the market average64.72% below the market average64.72% below the market average64.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.40% above the market average87.40% above the market average87.40% above the market average87.40% above the market average87.40% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 5
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 07-Aug-25 20-Feb-25
Paid 08-Sep-25 24-Mar-25
Amount 103.00¢ 210.00¢

Trades for 01-Aug-2025

Time Volume / Share Price
14:51 0 @ 11,146.00p
14:51 0 @ 11,146.00p
14:51 2 @ 11,146.00p
14:51 2 @ 11,152.00p
16:45 239,361 @ 11,043.10p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page